META vs TIGO

META exhibits exceptional fundamental health with a Piotroski F-Score of 8/9, indicating strong financial strength across profitability, leverage, and operating efficiency. While the current price of $612.42 trades at a premium to the Graham Number ($213.17) and the growth-based Intrinsic Value ($542.14), the PEG ratio of 0.94 suggests the stock is undervalued relative to its high growth rate. Strong revenue growth (23.8%) and a low forward P/E (17.03) outweigh the bearish technical trend and insider selling. The company's dominant market position and consistent earnings beats support a bullish long-term outlook.

TIGO exhibits a dichotomy between explosive growth and fragile financial health, evidenced by a stable but mediocre Piotroski F-Score of 4/9. While the stock trades significantly above its defensive Graham Number ($62.74), it remains well below its growth-based intrinsic value ($236.88), suggesting long-term upside if leverage is managed. However, a critical technical trend score of 10/100 and a current price ($83.43) exceeding the analyst target ($75.84) indicate a high probability of a short-term correction. The company's exceptional ROE (37.87%) is offset by a concerning Debt/Equity ratio of 2.62 and a liquidity crunch (Current Ratio 0.88).